{"id":"W2604822177","doi":"10.1007/s00277-017-2982-1","title":"Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia","year":2017,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Ottawa Hospital; BC Cancer Agency; Université Laval; University of Calgary; McGill University Health Centre","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Medicine; Fludarabine; Venetoclax; Idelalisib; Chronic lymphocytic leukemia; Alemtuzumab; Rituximab; Oncology; Internal medicine; Hematology; Cyclophosphamide; Salvage therapy; Transplantation; Leukemia; Immunology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006404174,0.0005931397,0.001203751,0.00210066,0.0002869244,0.0008214391,0.0008696835,0.0007733186,0.003992009],"category_scores_gemma":[0.0009096286,0.000197403,0.000668344,0.001403279,0.0003777328,0.001029592,0.0005561247,0.001818768,0.001660492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004812207,"about_ca_system_score_gemma":0.0008781353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009535072,"about_ca_topic_score_gemma":0.001673944,"domain_scores_codex":[0.9997396,0.00004966819,0.00004746292,0.00004176661,0.00009808749,0.00002345296],"domain_scores_gemma":[0.9996724,0.0001664562,0.00004713038,0.00001050787,0.00007677203,0.00002684202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005948713,0.00006382154,0.0001594871,0.01806349,0.00008361674,0.0001885418,0.00005676567,0.0002128058,0.0008475336,0.002220446,0.02504846,0.9529955],"study_design_scores_gemma":[0.00002066895,0.00008843219,0.0006645176,0.004904083,0.0001156596,0.001461539,0.00004346022,0.00004648114,0.0002352314,0.001304269,0.9911025,0.00001319699],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008602168,0.9988326,0.00004748208,0.0001707362,0.0001347674,0.000003383079,0.00001188436,0.000004185372,0.000708904],"genre_scores_gemma":[0.0005106783,0.9988601,0.00008859643,0.0001483872,0.0001312106,0.000003555061,0.00002317475,9.822257e-7,0.0002333591],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003992009,"threshold_uncertainty_score":0.01335466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1847946804722722,"score_gpt":0.4725117241757338,"score_spread":0.2877170437034616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}